Insider Shareholders with Direct Ownership of Reneo Pharmaceuticals, Inc. (RPHM)
This section provides a comprehensive overview of the insiders with direct ownership of Reneo Pharmaceuticals, Inc. (RPHM). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Reneo Pharmaceuticals, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
New Enterprise Associates 15, L.P.
> 10% Shareholder |
4,785,494 | 0 | 4,785,494 $8.04 Million | 1 |
Apr 13, 2021
Added 12.23%
|
|
Novo Holdings
> 10% Shareholder |
3,430,377 | 100,000 | 3,330,337 $5.59 Million | 2 |
Jun 23, 2023
Reduced 2.92%
|
|
Gregory J. Flesher
President and CEO |
108,000 | 0 | 109,600 $184,128 | 2 |
Dec 10, 2021
Added 47.71%
|
| 102,076 | 0 | 102,076 $171,487 | 1 |
Oct 07, 2024
Added 50.0%
|
|
|
Ashley Hall
Chief Development Officer |
45,625 | 15,625 | 39,600 $66,528 | 3 |
Aug 28, 2023
Reduced 28.29%
|
|
Vineet R. Jindal
Chief Financial Officer |
35,000 | 0 | 36,600 $61,488 | 2 |
Dec 10, 2021
Added 45.05%
|
|
Michael Cruse
Chief Operating Officer |
28,558 | 0 | 31,758 $53,353 | 4 |
Aug 30, 2022
Added 2.98%
|
|
Alejandro Dorenbaum
Chief Medical Officer |
30,000 | 22,348 | 30,000 $50,400 | 2 |
Aug 12, 2022
Reduced 42.69%
|
|
Jason A. Leverone
Chief Financial Officer |
16,331 | 0 | 16,331 $27,436 | 1 |
Oct 04, 2024
Added 50.0%
|
| 4,939 | 0 | 4,939 $8,297 | 1 |
Oct 04, 2024
Added 45.15%
|
|
|
Nicholas A Saccomano
President and CEO |
4,556 | 0 | 4,556 $7,654 | 1 |
Oct 04, 2024
Added 50.0%
|
| 50,000 | 50,000 | 0 $0 | 2 |
Jul 26, 2023
Reduced 100.0%
|
|
|
Wendy S. Johnson
Chief Development Officer |
111,736 | 111,736 | 0 $0 | 2 |
Jul 14, 2021
Reduced 100.0%
|